Search Results - "Auray, JP"

Prevalence and description of chronic daily headache in the general population in France by Lantéri-Minet, Michel, Auray, Jean-Paul, El Hasnaoui, Abdelkader, Dartigues, Jean-François, Duru, Gérard, Henry, Patrick, Lucas, Christian, Pradalier, André, Chazot, Guy, Gaudin, Anne-Françoise

“…The objective of this study was to describe the epidemiology, clinical presentation and consequences of chronic daily headache (CDH) in France. A…”
Get full text

Use and misuse of triptans in France: data from the GRIM2000 population survey by Lucas, C, Auray, J-P, Gaudin, A-F, Dartigues, J-F, Duru, G, Henry, P, Lantéri-Minet, M, Pradalier, A, Chazot, G, El Hasnaoui, A

“…The extent and nature of triptan use for headache relief has been evaluated in a large epidemiological survey in the French general population. Over 25 000…”
Get more information

Prevalence and clinical characteristics of migraine in France by HENRY, P, AURAY, J. P, GAUDIN, A. F, DARTIGUES, J. F, DURU, G, LANTERI-MINET, M, LUCAS, C, PRADALIER, A, CHAZOT, G, EL HASNAOUI, A

“…To determine the prevalence and clinical features of migraine and related headache types in France. The authors recruited a population of subjects with…”
Get full text

Economic impact of Migraine and other episodic headaches in France: Data from the GRIM2000 study by PRADALIER, André, AURAY, Jean-Paul, GAUDIN, Anne-Francois, EL HASNAOUI, Abdelkader, ALZAHOURI, Kazem, DARTIGUES, Jean-Francois, DURU, Gérard, HENRY, Patrick, LANTERI-MINET, Michel, LUCAS, Christian, CHAZOT, Guy

“…Migraine is a prevalent and incapacitating condition that affects individuals in the prime of their productive life, thus generating an economic burden for…”
Get full text

PRS23 FRENCH GATEKEEPING COST-EFFECTIVENESS IMPACT ON CHRONIC PATIENTS TREATED WITH INHALED CORTICOSTEROIDS, IN REAL LIFE by Maunoury, F, Van Hille, JL, Véron, N, Bounekkar, A, Fantino, B, Auray, JP, Launois, R

Get full text

PRS25 CAN THE FRENCH GATEKEEPING SYSTEM BE COST-EFFECTIVE FOR PATIENTS WITH CHRONIC RESPIRATORY DISORDER? by Maunoury, F, VanHille, JL, Véron, N, Bounekkar, A, Fantino, B, Auray, JP, Launois, R

Get full text

PMC14 POPULATION KNOWLEDGE: AN APPROACH TO CLASSIFY A GENERAL POPULATION ACCORDING TO LIFESTYLE, HEALTH BEHAVIOUR AND ATTITUDE by Auray, JP, Nicoloyannis, N, Dinet, J

Get full text

Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK by Daya, S., Ledger, W., Auray, J.P., Duru, G., Silverberg, K., Wikland, M., Bouzayen, R., Howles, C.M., Beresniak, A.

“…BACKGROUND: The purpose of this study was to undertake an economic evaluation to compare the cost-effectiveness of recombinant (r)FSH with urinary (u)FSH for…”
Get full text

Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States by Silverberg, Kaylen, Daya, Salim, Auray, Jean Paul, Duru, Gerald, Ledger, William, Wikland, Matts, Bouzayen, Renda, O'Brien, Mark, Falk, Barri, Beresniak, Ariel

“…To compare the cost effectiveness of recombinant human FSH (Gonal-F; Serono, Inc., Randolph, MA) and urinary FSH (Fertinex; Serono, Inc.) for ovarian…”
Get more information

Impact of Headache on Quality of Life in a General Population Survey in France (GRIM2000 Study) by Duru, Gérard, Auray, Jean-Paul, Gaudin, Anne-Françoise, Dartigues, Jean-François, Henry, Patrick, Lantéri-Minet, Michel, Lucas, Christian, Pradalier, André, Chazot, Guy, Hasnaoui, Abdelkader El

“…Objectives.—The objectives of this study were to determine the impact of headache on health‐related quality of life in a nationwide sample of the French…”
Get full text

Limitations of the methods used for calculating quality-adjusted life-year values by Duru, Gérard, Auray, Jean Paul, Béresniak, Ariel, Lamure, Michel, Paine, Abby, Nicoloyannis, Nicolas

“…To test the validity of the techniques used to calculate quality-adjusted life-year (QALY) values based on utility functions, using a real population dataset…”
Get full text

Quality of life and economic cost of multiple sclerosis by Grimaud, J, Auray, J-P

“…In multiple sclerosis, evaluation of quality of life is important because the patients are usually confronted with a decrease in physical, cognitive and social…”
Get more information

PMW6 COST EFFECTIVENESS MODELING COMPARING RECOMBINANT FSH WITH URINARY FSH FOR OVARIAN STIMULATION—A MULTINATIONAL EVALUATION by Beresniak, A, Daya, S, Duru, G, Auray, JP

Get full text

Clinically relevant differences and "Biocreep" by Auray, Jean-Paul, Duru, Gerard

Get more information

CE1 COST-EFFECTIVENESS MODEL OF RECOMBINANT HUMAN CHORIONIC GONADOTROPIN (R-HCG) VERSUS URINARY HCG (U-HCG) FOR ASSISTED REPRODUCTIVE TECHNIQUES (ART) IN THE USA by Beresniak, A, Daya, S, Auray, JP, Schertz, J, Silverberg, K, DeCherney, AH

Get full text

PNP3 SOCIO-ECONOMIC IMPACT OF CHRONIC DAILY HEADACHE IN THE GENERAL POPULATION IN FRANCE by Lantéri-Minet, M, Auray, JP, Chazot, G, Dartigues, JF, Duru, G, Henry, P, Lucas, C, Pradalier, A, el Hasnaoui, A, Gaudin, AF

Get full text

Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish Public Health Care System by ROMEU, Alberto, BALASCH, Juan, RUIZ BALDA, José A, BARRI, Pedro N, DAYA, Salim, AURAY, Jean P, DURU, Gerald, BERESNIAK, Ariel, PEINADO, José A

“…To evaluate the relative cost-effectiveness of recombinant and urinary follicle-stimulating hormone (FSH) in assisted reproduction techniques in the Spanish…”
Get full text

PNP1 SOCIO-ECONOMIC IMPACT OF MIGRAINE IN FRANCE IN 2000 by Pradalier, A, Auray, JP, Duru, G, Chazot, G, Dartigues, JF, Henry, P, Lanteri-Minet, M, Lucas, C, El Hasnaoui, A, Gaudin, AF

Get full text

PNP7 THE MIGRAINE IN FRANCE IN 2000 by Henry, P, Auray, JP, Duru, G, Chazot, G, Dartigues, JF, Lanteri-Minet, M, Lucas, C, Pradalier, A, El Hasnaoui, A, Gaudin, AF

Get full text

PGS2: PHARMACOECONOMIC MODELING IN ASSISTED REPRODUCTION TECHNOLOGIES: RECOMBINANT FSH VERSUS URINARY FSH by Auray, JP, Duru, G, Daya, S, Ledger, W, Silverberg, K, Wikland, M, Bouzayen, R, Howies, C, Beresniak, A

Get full text